We are live on ! Find out more
NIM

Northeast Investment Management Portfolio holdings

AUM $2.71B
1-Year Est. Return 25.45%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+25.45%
3 Year Est. Return
+93.39%
5 Year Est. Return
+114.23%
10 Year Est. Return
+466.58%
AUM
$994M
AUM Growth
+$21.1M
Cap. Flow
+$3.98M
Cap. Flow %
0.4%
Top 10 Hldgs %
27.23%
Holding
159
New
6
Increased
56
Reduced
71
Closed
4

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$4.38M
2
SF
Stifel
SF
+$2.76M
3
ABT icon
Abbott
ABT
+$2M
4
NVO
Novo Nordisk
NVO
+$1.91M
5
DIS icon
Walt Disney
DIS
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 17.49%
2 Financials 12.74%
3 Industrials 12.38%
4 Consumer Discretionary 10.08%
5 Technology 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
1
Visa
V
$686B
$32M 3.22%
431,417
-10,109
-2% -$792K
DIS icon
2
Walt Disney
DIS
$174B
$30.9M 3.11%
315,975
-13,798
-4% -$1.38M
JNJ icon
3
Johnson & Johnson
JNJ
$621B
$30.2M 3.04%
248,886
+1,333
+0.5% +$151K
AAPL icon
4
Apple
AAPL
$4.51T
$28.3M 2.85%
1,184,712
-19,024
-2% -$473K
CVS icon
5
CVS Health
CVS
$127B
$28.1M 2.83%
293,425
-5,226
-2% -$521K
GE icon
6
GE Aerospace
GE
$395B
$26.6M 2.68%
176,376
-1,451
-0.8% -$212K
BRK.B icon
7
Berkshire Hathaway Class B
BRK.B
$1.11T
$24.8M 2.5%
171,416
-1,523
-0.9% -$218K
UNP icon
8
Union Pacific
UNP
$176B
$23.9M 2.41%
274,252
-2,448
-0.9% -$207K
XOM icon
9
ExxonMobil
XOM
$632B
$23.2M 2.33%
247,266
+3,987
+2% +$353K
MMM icon
10
3M
MMM
$94.1B
$22.7M 2.29%
155,274
-988
-0.6% -$139K
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.44T
$22.4M 2.26%
638,200
+7,260
+1% +$266K
HON icon
12
Honeywell
HON
$78.7B
$22.4M 2.26%
214,753
+4,086
+2% +$420K
AMZN icon
13
Amazon
AMZN
$2.94T
$22.1M 2.23%
618,380
+30,140
+5% +$1.02M
VNQ icon
14
Vanguard Real Estate ETF
VNQ
$39B
$21.7M 2.18%
244,696
+5,036
+2% +$423K
META icon
15
Meta Platforms (Facebook)
META
$1.48T
$21.5M 2.16%
187,973
+17,594
+10% +$2.03M
BMY icon
16
Bristol-Myers Squibb
BMY
$130B
$20.6M 2.07%
279,765
+28,494
+11% +$2.01M
MANH icon
17
Manhattan Associates
MANH
$11.1B
$20.4M 2.05%
317,800
-9,639
-3% -$601K
GILD icon
18
Gilead Sciences
GILD
$162B
$20.2M 2.03%
242,199
-6,971
-3% -$619K
AKAM icon
19
Akamai
AKAM
$18B
$19.8M 1.99%
354,493
-3,321
-0.9% -$175K
AMT icon
20
American Tower
AMT
$77.6B
$19.8M 1.99%
174,226
-1,851
-1% -$197K
VCSH icon
21
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$17.1M 1.72%
212,095
+1,021
+0.5% +$81.9K
CVX icon
22
Chevron
CVX
$373B
$16.5M 1.65%
156,961
+3,655
+2% +$368K
DHR icon
23
Danaher
DHR
$141B
$16.4M 1.65%
241,551
+10,302
+4% +$674K
TROW icon
24
T. Rowe Price
TROW
$24.7B
$15.9M 1.6%
217,373
-3,562
-2% -$265K
SLB icon
25
SLB Ltd
SLB
$74.6B
$15.5M 1.56%
196,230
+4,795
+3% +$368K

Similar funds

Northeast Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Northeast Investment Management held 159 positions worth $994M, up 2.2% from $973M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Northeast Investment Management's Q2 2016 filing shows 6 new, 56 increased, 71 reduced and 4 closed positions. Its largest new stake was Becton Dickinson: 7,355 shares worth $1.22M. The largest sale was Novartis, an estimated $4.38M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.

  • Northeast Investment Management's largest Q2 2016 buy was Becton Dickinson: 7,355 shares worth $1.22M.
  • Northeast Investment Management added most to Thermo Fisher Scientific in Q2 2016, an estimated $4.26M increase.
  • Northeast Investment Management's biggest Q2 2016 reduction was Novartis, cutting an estimated $4.38M.
  • Northeast Investment Management fully exited Biogen in Q2 2016, selling an estimated $431K.
  • Northeast Investment Management's ten largest holdings make up 27% of its $994M portfolio in Q2 2016.
  • Northeast Investment Management opened 6 new positions and closed 4 in Q2 2016.
  • Northeast Investment Management's portfolio value rose 2.2% quarter-over-quarter to $994M.

Based on Northeast Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.